Publications by authors named "Alex McCormick"

Claim this Profile
P
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.
Catherine Hanna, Kathreena M Kurian, Karin Williams, Colin Watts, Alan Jackson, Alex McCormick

Neuro Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar).
Jamie M Pitlick, Ginelle A Bryant, Michael W Daly, Carrie F Koenigsfeld, Nicholas Lehman, Alex McCormick

Ann Pharmacother· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
Alex McCormick, Helen Swaisland, Venkatesh Pilla Reddy, Maria Learoyd, Graeme Scarfe

Xenobiotica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assessment of the roles of drug transporters in the disposition and drug-drug interaction potential of olaparib.
Alex McCormick, Helen Swaisland

Xenobiotica· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics and Pharmacodynamics of Cediranib.
Weifeng Tang, Alex McCormick, Jianguo Li, Eric Masson

Clin Pharmacokinet· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Drug Metabolism Discussion Group in 2011.
Michael Hall, Kevin Brady, Iain Gardner, Alex McCormick, Andrew McEwen

Xenobiotica· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis